Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Tsumura & Co ( (JP:4540) ) is now available.
Tsumura & Co reported significant growth in its financial performance for the third quarter ending December 31, 2024, with net sales increasing by 18.1% and operating profit surging by 69.1% year-on-year. This robust financial performance is attributed to the company’s strategic focus on expanding its product line and optimizing operations, positioning it strongly in the market. The company also revised its full-year financial projections upwards, signaling confidence in sustained growth and positive implications for stakeholders.
More about Tsumura & Co
Tsumura & Co is a company listed on the Tokyo Stock Exchange, operating within the pharmaceutical industry. It specializes in the production and distribution of traditional Japanese herbal medicines, focusing on Kampo products which are derived from natural ingredients.
YTD Price Performance: -3.64%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.23B
Learn more about 4540 stock on TipRanks’ Stock Analysis page.
